Stryker Buys Ortho Oncology Specialist Stanmore Implants

The approximately $52 million deal increases Stryker's offerings for limb-salvage procedures for cancer patients.

Stryker Corp. has laid out about $52 million to buy UK-based Stanmore Implants Worldwide Ltd., enhancing its focus on limb-salvage products for cancer patients.

The orthopedics giant announced completion of the deal April 29, touting Stanmore's specialized products for adults and kids being treated...

More from Strategy

More from Business